Skip to main content

Conference Correspondent

News, views, and coverage of important topics and discussions from oncology conferences and events.

[widgetkit id="1" name="CC Event Nav"]

ASCO 2020 - Lung Cancer

ASCO 2020 Lung Cancer Highlights

ASCO 2020 - Lung Cancer

Impact of Immune-Related Adverse Events on Checkpoint Inhibitor Consolidation Therapy in Stage III NSCLC

ASCO 2020 - Lung Cancer

Characteristics of Patients Who Achieve Long-Term Response with PD-1 Blockade

ASCO 2020 - Lung Cancer

Smoking Cessation and Lung Cancer: Recent Quitters Benefit Too

ASCO 2020 - Lung Cancer

Weekly Epirubicin as Second-Line Therapy for Malignant Pleural Mesothelioma

ASCO 2020 - Lung Cancer

Patterns of Acquired Resistance in Patients with NSCLC Who Receive PD-1 Inhibitors

ASCO 2020 - Lung Cancer

ADAURA Results: Osimertinib as Adjuvant Therapy for EGFR-Mutated NSCLC

ASCO 2020 - Lung Cancer

Cediranib Combined with Olaparib Is Active in Patients with Platinum-Pretreated SCLC

ASCO 2020 - Lung Cancer

Nationwide Genomic Screening Network Can Be Effective in Identifying Rare Targetable Genetic Alterations

ASCO 2020 - Lung Cancer

Combination of Nivolumab, Ipilimumab, and Chemotherapy in Metastatic NSCLC

1
2
3
4

Page 1 of 25
Results 1 - 10 of 242